| Clinical data | |
|---|---|
| Routes of administration | Oral |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C13H19NO2 |
| Molar mass | 221.300 g·mol−1 |
| 3D model (JSmol) | |
| |
Ifoxetine (CGP-15,210-G) is aselective serotonin reuptake inhibitor (SSRI) which was investigated as anantidepressant in the 1980s but was never marketed.[1][2][3] Ifoxetineselectively blocks thereuptake ofserotonin in thebrain supposedly without affecting it in theperiphery.[3] Supporting this claim, ifoxetine was found to be efficacious inclinical trials and was very well tolerated, producing almost nophysicalside effects or other complaints of significant concern.[3]
Thisdrug article relating to thenervous system is astub. You can help Wikipedia byexpanding it. |